IN VIVO is your go-to strategically-focused business resource covering the global biopharma, medech and diagnostics industries. IN VIVO delivers revealing, in-depth coverage of your competitors' strategies; incisive projections of future industry trends and their implications for your business; expert analysis of key industry developments; exclusive interviews with top industry executives and analysts; and in-depth examination of deal-making, marketing R&D, regulatory, and finance strategies.
A subscription will bring you deep insight and analysis on the strategic implications of key industry events and trends which will help you make informed, effective and profitable decisions. With a global editorial team covering the whole drug value chain, IN VIVO provides business intelligence helping you build your business plans and keep you up-to-date with the latest market developments.
IN VIVO is now published on a new user-friendly, interactive and responsive website. It includes a hugely improved faceted search capability allowing you to access relevant stories and articles of interest much faster. IN VIVO now has a simplified homepage and a new topic page bringing you closer to the content that matters most. Enjoy seamless navigation and access all your products on mobile, PC and tablet keeping you informed whilst on the move.
Leading industry insight on a leading industry platform
The new website allows you to access a large amount of relevant content from one place. The ability to create custom email alerts, numerous ways to refine and target search results, and simple tools to collect, send and share content allows you to tailor the service to your exact requirements.
Related articles, deals, companies, regions, therapy areas and other subjects are listed on the same page. This means that you can identify, find and read the content without having to look for it, making the website a valuable time saving resource.
Subscribe today and benefit from:
- The latest on biopharma, medtech and diagnostic strategies with insights on how to grow product revenues.
- The most relevant deal-making, regulatory, commercial and financial news and analysis.
- Feature articles on hot topics in R&D, investment technology, clinical trials, deal-making in depth, M&A activity and business developments.
- In-depth profiles of leading-edge companies assessing new trends and technologies.
- Competitor product launches and industry wide drug strategy updates.
- Customize and deepen your knowledge of commercial & competitive environment via custom email alerts to get the full picture.
- Refine your search so you just see news/analysis/opinion by media type (listen/watch/read)
- Scan headlines to be up-to-date on the latest, and tailor the service to your specific needs with refined targeted searches, and custom email alerts and RSS feeds so you never miss a development.
- “Ask the Analyst” exclusive client service to find out more about market access topics, developments, or trends to support presentations, proposals, or business critical decisions where your credibility is on the line.
To Speak with a Sales Representative:
If you would like to speak with one of our knowledgeable Sales Representatives, please reach out as follows:
- Email: PharmaNewsSales@informa.com
- Phone (US) +1 212-520-2765
- Phone (UK & Europe): +44 (0) 20 7017-4191
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.